Table 5.
Control Group | NP Group | p Value | |
---|---|---|---|
Variables | n = 13 | n = 12 | |
Off-bed time (days) | 5.5 ± 0.8 | 4.6 ± 1.1 | 0.028 * |
Drainage amount (mL) | 166.8 ± 62.9 | 156.9 ± 57.3 | 0.701 |
Vacuum ball removed timing (post-op days) | 8.4 ± 1.4 | 7.7 ± 1.5 | 0.269 |
Vancouver scar scale | 5.3 ± 2.9 | 5.8 ± 2.5 | 0.693 |
Re-exploration | 2 (15.4%) | 1 (8.3%) | 1.000 |
Donor site acute complications (<30 days) | 3 (23.1%) | 0 | 0.22 |
Wound breakdown required surgery | 2 | 0 | |
Wound dehiscence with wound care | 1 | 0 | |
Donor site long-term complications (>30 days) | 3 (23.1%) | 1 (8.3%) | 0.593 |
Wound breakdown required surgery | 1 | 1 | |
Wound dehiscence with wound care | 2 | 0 | |
Donor-site revision | 3 (23.1%) | 2 (16.7%) | 1.000 |
Lower limb lymphedema | 0 | 0 | |
Distortion of major labia | 0 | 0 |
Data are presented as n (%) or mean ± standard deviation. NP, negative pressure. * p < 0.05.